No effective screening test is available for HGSOC, and patients often present in an advanced stage of disease. Around 70%–80% of deaths from ovarian cancer are caused by HGSOC.[1][1] This cancer develops via a stepwise progression within the distal fallopian tube epithelium. The precursor lesion